Corneal collagen cross-linking (CXL) halts human corneal ectasias progression by increasing stromal mechanical stiffness. Although some reports describe that this procedure is effective in dealing wit
Global Corneal Cross Linking Device Market Report 2022 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past mark
PurposeThe purpose of the study is to compare the efficacy of standard epithelium-off CXL (SCXL), accelerated epithelium-off CXL (ACXL), and transepithelial crosslinking CXL (TECXL) for pediatric kera
Details of pre-treatment tissue hydration (recorded at the time of data collection), classification and UVA cross-linking treatment (hypo-osmolar/iso-osmolar riboflavin solution) are shown for each sa
Kmax = maximum keratometry value; D = diopters; NR: Not reported. *Corneal collagen cross-linking group/Control group; †Corneal collagen cross-linking group/Sham control group/Fellow-Eye control group